Antisense modulation of MEKK1 expression
US6168950A · kind A · utility
9Cited by
3References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 1999 |
| Grant date | Jan 2, 2001 |
| Priority date | — |
| Expiry date | Jul 23, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of MEKK1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding MEKK1. Methods of using these compounds for modulation of MEKK1 expression and for treatment of diseases associated with expression of MEKK1 are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.